WHO ICTRP trial
Analysis of blood metabolites after HBAIC1808 intake.
JPRN-UMIN000034281 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000034281 |
|---|---|
| Public title | Analysis of blood metabolites after HBAIC1808 intake. |
| Scientific title | Analysis of blood metabolites after HBAIC1808 intake. - Analysis of blood HBAIC1808 metabolites. |
| Primary sponsor | Kao Corporation |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Healthy adults |
| Interventions | -Oral administration of a placebo capsule and collecting blood samples. -Oral administration of an active drink every day for 3 weeks. --Oral administration of an active capsule and collecting blood samples. |
| Registration date | Sep 27, 2018 |
| Target size | 10 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: